Cargando…
Brugada Syndrome: More than a Monogenic Channelopathy
Brugada syndrome (BrS) is an inherited cardiac channelopathy first diagnosed in 1992 but still considered a challenging disease in terms of diagnosis, arrhythmia risk prediction, pathophysiology and management. Despite about 20% of individuals carrying pathogenic variants in the SCN5A gene, the iden...
Autores principales: | Liantonio, Antonella, Bertini, Matteo, Mele, Antonietta, Balla, Cristina, Dinoi, Giorgia, Selvatici, Rita, Mele, Marco, De Luca, Annamaria, Gualandi, Francesca, Imbrici, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452102/ https://www.ncbi.nlm.nih.gov/pubmed/37626795 http://dx.doi.org/10.3390/biomedicines11082297 |
Ejemplares similares
-
Functional Characterization of Two Novel Mutations in SCN5A Associated with Brugada Syndrome Identified in Italian Patients
por: Balla, Cristina, et al.
Publicado: (2021) -
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016) -
Sarcoplasmic Reticulum Ca(2+) Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease
por: Conte, Elena, et al.
Publicado: (2023) -
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach
por: Mele, Marco, et al.
Publicado: (2023) -
Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches
por: D’Adamo, Maria Cristina, et al.
Publicado: (2020)